Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

AMNESTEEM 20 MG CAPSULE

isotretinoin
$1.7937per EA

Strength

20 mg/1

Manufacturer

Mylan Pharmaceuticals Inc.

NDC

00378661293

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ISOTRETINOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA075945

On Market Since

11/11/2002

Pharmacological Classes

Retinoid
Retinoids

Price History

1W

0.0%

1M

+0.6%

3M

-1.7%

6M

-18.7%

1Y

-24.7%

3Y

-25.1%

5Y

-38.6%

All

-73.0%

Generic Alternatives

1 alternative • Same active ingredient

ABSORICA 20 MG CAPSULE
Brand
10631011631•Sun Pharmaceutical Industries Inc.
$35.3489
+1871% more

Related Drugs

Same classification

ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
21922005250•Encube Ethicals, Inc.
$0.3038
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
45802084601•Padagis Israel Pharmaceuticals Ltd
$0.3038
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
51672136403•Sun Pharmaceutical Industries Inc.
$0.3038
per GM
ADAPALENE-BNZYL PEROX 0.1-2.5%
Generic
68462030147•Glenmark Pharmaceuticals Inc., USA
$0.3038
per GM
ADAPALENE 0.1% GEL
Generic
00536141226•Rugby Laboratories
$0.3555
per GM
ADAPALENE 0.1% GEL
Generic
51672215006•Sun Pharmaceutical Industries Inc.
$0.3555
per GM
ADAPALENE 0.1% GEL
Generic
00536141220•Rugby Laboratories
$0.4317
per GM
GNP ADAPALENE 0.1% GEL
Generic
46122076836•AmerisourceBergen
$0.4317
per GM
ADAPALENE 0.1% GEL
Generic
51672215001•Sun Pharmaceutical Industries Inc.
$0.4317
per GM
ADAPALENE 0.3% GEL
Generic
00472012645•Actavis Pharma, Inc.
$0.5076
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy